ESTALIS SEQUI
ESTALIS SEQUI
Discontinued
DIN Number
02243529
Drug Class
Human
Market Date
Jun 26, 2001
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243529
AIG Number0336586002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03FB05 NORETHISTERONE AND ESTROGEN
Product Specifications
Dosage FormPatch
Route of AdministrationTransdermal
AHFS Classification68:16.04
Health Canada Classification
ACTIVE INGREDIENTS (3)
ESTRADIOLActive
Strength: 0.62 MG
Monograph: ESTRADIOL
ESTRADIOLActive
Strength: 4.33 MG
Monograph: ESTRADIOL
NORETHINDRONE ACETATEActive
Strength: 2.7 MG
Monograph: NORETHINDRONE ACETATE